KINEPOLIS (KIN.BR) Stock Fundamental Analysis

Europe • Euronext Brussels • EBR:KIN • BE0974274061

27.35 EUR
-0.1 (-0.36%)
Last: Feb 10, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to KIN. KIN was compared to 48 industry peers in the Entertainment industry. KIN has a medium profitability rating, but doesn't score so well on its financial health evaluation. KIN scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year KIN was profitable.
  • KIN had a positive operating cash flow in the past year.
  • In multiple years KIN reported negative net income over the last 5 years.
  • KIN had a positive operating cash flow in 4 of the past 5 years.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • KIN has a Return On Assets of 4.54%. This is in the better half of the industry: KIN outperforms 75.00% of its industry peers.
  • KIN's Return On Equity of 23.61% is amongst the best of the industry. KIN outperforms 83.33% of its industry peers.
  • KIN has a better Return On Invested Capital (8.28%) than 77.08% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for KIN is below the industry average of 9.48%.
  • The 3 year average ROIC (6.76%) for KIN is below the current ROIC(8.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • KIN has a Profit Margin of 7.98%. This is in the better half of the industry: KIN outperforms 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of KIN has declined.
  • KIN has a Operating Margin of 15.19%. This is amongst the best in the industry. KIN outperforms 91.67% of its industry peers.
  • KIN's Operating Margin has declined in the last couple of years.
  • KIN has a Gross Margin of 24.54%. This is amonst the worse of the industry: KIN underperforms 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of KIN has declined.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KIN is still creating some value.
  • Compared to 1 year ago, KIN has about the same amount of shares outstanding.
  • Compared to 5 years ago, KIN has more shares outstanding
  • Compared to 1 year ago, KIN has an improved debt to assets ratio.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • KIN has an Altman-Z score of 1.50. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.50, KIN is doing good in the industry, outperforming 60.42% of the companies in the same industry.
  • The Debt to FCF ratio of KIN is 5.38, which is a neutral value as it means it would take KIN, 5.38 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 5.38, KIN perfoms like the industry average, outperforming 52.08% of the companies in the same industry.
  • KIN has a Debt/Equity ratio of 2.87. This is a high value indicating a heavy dependency on external financing.
  • KIN has a Debt to Equity ratio of 2.87. This is in the lower half of the industry: KIN underperforms 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.5
ROIC/WACC1.39
WACC5.96%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • KIN has a Current Ratio of 0.47. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of KIN (0.47) is worse than 87.50% of its industry peers.
  • A Quick Ratio of 0.44 indicates that KIN may have some problems paying its short term obligations.
  • The Quick ratio of KIN (0.44) is worse than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

  • KIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.32%, which is quite impressive.
  • Measured over the past years, KIN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.80% on average per year.
  • Looking at the last year, KIN shows a small growth in Revenue. The Revenue has grown by 5.38% in the last year.
  • The Revenue has been growing slightly by 0.95% on average over the past years.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

  • Based on estimates for the next years, KIN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.94% on average per year.
  • Based on estimates for the next years, KIN will show a small growth in Revenue. The Revenue will grow by 4.98% on average per year.
EPS Next Y19.98%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
EPS Next 5Y14.94%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 15.99, the valuation of KIN can be described as correct.
  • 91.67% of the companies in the same industry are more expensive than KIN, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 28.03, KIN is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 10.30, the valuation of KIN can be described as reasonable.
  • 85.42% of the companies in the same industry are more expensive than KIN, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, KIN is valued rather cheaply.
Industry RankSector Rank
PE 15.99
Fwd PE 10.3
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, KIN is valued a bit cheaper than the industry average as 70.83% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, KIN is valued cheaper than 85.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.73
EV/EBITDA 8.11
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • KIN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • KIN's earnings are expected to grow with 21.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y25.83%
EPS Next 3Y21.15%

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.40%, KIN has a reasonable but not impressive dividend return.
  • KIN's Dividend Yield is a higher than the industry average which is at 0.87.
  • KIN's Dividend Yield is slightly below the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.4%

5.2 History

  • The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 31.09% of the earnings are spent on dividend by KIN. This is a low number and sustainable payout ratio.
DP31.09%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (2/10/2026, 7:00:00 PM)

27.35

-0.1 (-0.36%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21
Earnings (Next)02-20
Inst Owners17.67%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap748.57M
Revenue(TTM)593.29M
Net Income(TTM)47.32M
Analysts86
Price Target46.46 (69.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.4%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.76%
PT rev (3m)-5.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.37%
EPS NY rev (3m)-5.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 15.99
Fwd PE 10.3
P/S 1.26
P/FCF 5.73
P/OCF 4.31
P/B 3.73
P/tB 33.4
EV/EBITDA 8.11
EPS(TTM)1.71
EY6.25%
EPS(NY)2.65
Fwd EY9.71%
FCF(TTM)4.77
FCFY17.45%
OCF(TTM)6.34
OCFY23.18%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.8
PEG (5Y)N/A
Graham Number16.79
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.5
F-Score8
WACC5.96%
ROIC/WACC1.39
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y19.98%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
EPS Next 5Y14.94%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year104.02%
EBIT Next 3Y35.57%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%

KINEPOLIS / KIN.BR FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 4 / 10 to KIN.BR.


Can you provide the valuation status for KINEPOLIS?

ChartMill assigns a valuation rating of 7 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of KINEPOLIS (KIN.BR) stock?

The Price/Earnings (PE) ratio for KINEPOLIS (KIN.BR) is 15.99 and the Price/Book (PB) ratio is 3.73.


Is the dividend of KINEPOLIS sustainable?

The dividend rating of KINEPOLIS (KIN.BR) is 3 / 10 and the dividend payout ratio is 31.09%.